By Counterforce Health Team in Elelyso (taliglucerase alfa) —

How to Get Elelyso (Taliglucerase Alfa) Covered by UnitedHealthcare in Pennsylvania: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Elelyso Covered by UnitedHealthcare in Pennsylvania

UnitedHealthcare requires prior authorization for Elelyso (taliglucerase alfa) and typically prefers VPRIV as first-line therapy for Type 1 Gaucher disease. Your fastest path to approval:

  1. Submit PA request via UnitedHealthcare Provider Portal with confirmed Gaucher disease diagnosis (enzyme assay or genetic testing)
  2. Document medical necessity: Include clinical symptoms, lab results, and specialist consultation
  3. If denied, file internal appeal within 180 days, then Pennsylvania external review within 4 months

Start today: Gather your diagnosis confirmation, treatment history, and current symptoms documentation. Pennsylvania's external review program overturns ~50% of denials.

Table of Contents

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required before dispensing UnitedHealthcare Provider Portal UHC PA Requirements
Step Therapy VPRIV preferred first May need to try/fail preferred agent UHC Medical Drug Policy
Age Requirement 4 years and older FDA labeling requirement FDA Access Data
Diagnosis Confirmation Enzyme assay or genetic testing Clinical documentation required UHC Medical Necessity Criteria
Billing Code HCPCS J3060 For claim submission CMS HCPCS

Step-by-Step: Fastest Path to Approval

1. Confirm Your Diagnosis Documentation

Who: Your specialist or primary care doctor
What: Beta-glucocerebrosidase enzyme assay showing deficiency OR genetic testing confirming Gaucher disease
Timeline: Before PA submission
Source: UHC Medical Drug Policy

2. Gather Clinical Evidence

Who: Healthcare team
What: Document at least one of these symptoms:

  • Anemia or thrombocytopenia (platelet count ≤120,000/mm³)
  • Bone disease (lesions, fractures, osteopenia)
  • Hepatosplenomegaly or symptomatic splenomegaly
  • Growth retardation or quality of life impairment
    Timeline: Current within 6 months

3. Submit Prior Authorization

Who: Prescribing physician or authorized staff
What: Complete PA request through UnitedHealthcare Provider Portal
How: Log into provider portal → Prior Authorization → Specialty Drugs
Timeline: Allow 5-7 business days for standard review
Source: UHC Provider Portal

4. Address Step Therapy Requirements

Who: Prescriber
What: If VPRIV is required first, document contraindications, prior failure, or intolerance
Include: Previous treatment dates, adverse reactions, lack of clinical response
Timeline: Submit with initial PA or as additional documentation

5. Monitor PA Status

Who: Patient or clinic staff
What: Check approval status via provider portal or member services
Contact: UHC Provider Services at (877) 842-3210
Timeline: Follow up if no response within 7 business days

Common Denial Reasons & Solutions

Denial Reason How to Overturn Required Documentation
"Step therapy not completed" Document VPRIV contraindication or failure Prior treatment records, adverse event notes, specialist letter
"Not medically necessary" Strengthen clinical justification Updated lab values, symptom progression, functional assessments
"Missing clinical information" Submit complete medical records Enzyme assay results, genetic testing, imaging studies
"Age restriction" Confirm patient ≥4 years old Birth certificate or medical record verification
"Duplicate therapy" Clarify no concurrent ERT/SRT use Current medication list, pharmacy records
Tip: Most denials can be overturned with complete documentation. Don't assume the first denial is final.

Internal Appeals Process

Level 1: Standard Internal Appeal

Deadline: 180 days from denial notice
How to Submit: UnitedHealthcare Provider Portal (electronic submission required starting June 2, 2025)
Decision Timeline: 72 hours for standard appeals
Source: UHC Appeals Process

Level 2: Peer-to-Peer Review

When Available: After Level 1 denial (if permitted by plan)
How to Request: Contact number provided in denial letter
Preparation: Have clinical summary, treatment rationale, and guideline references ready
Timeline: Must request within 5-10 business days of denial notice

Expedited Appeals

Eligibility: When delay could seriously jeopardize health
Timeline: 24 hours for decision
How to Request: Mark "expedited" on appeal form and provide clinical justification

Pennsylvania External Review Process

Pennsylvania's Independent External Review Program launched in January 2024, providing a powerful option for overturning UnitedHealthcare denials.

Eligibility Requirements

  • Must exhaust UnitedHealthcare's internal appeals first
  • Receive Final Adverse Benefit Determination letter
  • File within 4 months of final internal denial
  • Applies to commercial insurance (not self-funded employer plans)

How to Submit

Online: PA.gov External Review Portal
Forms: Download Independent External Review Request Form from PA.gov
Timeline: 45 days for standard review, 72 hours for expedited cases
Success Rate: ~50% of appeals are overturned in favor of patients

Required Documentation

  • Final denial letter from UnitedHealthcare
  • All internal appeal correspondence
  • Complete medical records supporting necessity
  • Physician statement of medical necessity
  • Any additional clinical evidence
Note: Pennsylvania's external review decision is binding on UnitedHealthcare and must be implemented within 24 hours for expedited cases.

Medical Necessity Documentation Checklist

Clinician Corner: Building Your Case

Essential Elements for Medical Necessity Letter:

  • Confirmed Diagnosis: Beta-glucocerebrosidase enzyme deficiency results or genetic testing
  • Clinical Manifestations: Document specific symptoms and their impact
  • Treatment History: Previous therapies tried, responses, and reasons for discontinuation
  • Contraindications: Why preferred agents (VPRIV) cannot be used
  • Treatment Goals: Expected clinical outcomes with Elelyso therapy
  • Monitoring Plan: How you'll assess treatment response

Supporting Documentation:

  • Laboratory results (CBC, comprehensive metabolic panel)
  • Imaging studies (if bone involvement)
  • Specialist consultation notes
  • Quality of life assessments
  • Growth charts (for pediatric patients)

Guideline References:

Templates & Scripts

Patient Phone Script for UnitedHealthcare

"Hello, I'm calling about a prior authorization denial for Elelyso (taliglucerase alfa) for my Type 1 Gaucher disease. My member ID is [ID number]. I'd like to understand the specific reasons for denial and the appeals process. Can you transfer me to someone who can help with specialty drug appeals?"

Medical Necessity Letter Template

[Date]
UnitedHealthcare Medical Management
Re: [Patient Name], DOB: [Date], Member ID: [Number]
Request for: Elelyso (taliglucerase alfa) - HCPCS J3060

CLINICAL SUMMARY:
[Patient name] is a [age]-year-old with confirmed Type 1 Gaucher disease diagnosed by [enzyme assay/genetic testing] on [date].

CURRENT CLINICAL STATUS:
- [Specific symptoms: anemia, thrombocytopenia, organomegaly, bone disease]
- [Laboratory values with dates]
- [Functional impact on daily activities]

TREATMENT RATIONALE:
[Specific medical reasons why Elelyso is medically necessary, including any contraindications to preferred agents]

EXPECTED OUTCOMES:
[Clinical goals and monitoring plan]

Respectfully,
[Physician name and credentials]

Cost Assistance Options

Manufacturer Support

Pfizer Patient Assistance Program: May provide Elelyso at reduced cost for eligible patients
Contact: Visit Pfizer.com patient assistance section (verify current program availability)
Eligibility: Typically based on income and insurance status

Foundation Grants

National Gaucher Foundation: Provides financial assistance for treatment-related expenses
Contact: National Gaucher Foundation (verify current programs)

State Programs

Pennsylvania PACE: Prescription assistance for seniors
Pennsylvania CHIP: Coverage for children in qualifying families
Contact: Pennsylvania Department of Human Services (verify eligibility)

When to Escalate

If your appeals are unsuccessful, you can file a complaint with:

Pennsylvania Insurance Department
Office of Consumer Services
Phone: (877) 881-6388
Online: PA.gov Insurance Complaints

Required Documents:

  • All denial and appeal correspondence
  • Medical records
  • Timeline of events
  • Specific harm caused by denial

For patients and healthcare providers navigating complex insurance denials, Counterforce Health helps turn insurance denials into targeted, evidence-backed appeals. The platform analyzes denial letters, identifies the specific basis for denial, and drafts point-by-point rebuttals aligned with each payer's own rules, significantly improving approval rates for specialty medications like Elelyso.

FAQ

How long does UnitedHealthcare prior authorization take in Pennsylvania?
Standard PA requests typically take 5-7 business days. Expedited requests (when delay poses health risks) must be processed within 24-72 hours depending on the plan type.

What if Elelyso is non-formulary on my plan?
Non-formulary medications can still be covered through medical exception processes. You'll need stronger clinical justification and may face higher copays.

Can I request an expedited appeal?
Yes, if delay in treatment could seriously jeopardize your health or life. Mark your appeal as "expedited" and provide clinical documentation of urgency.

Does step therapy apply if I've tried other ERTs outside Pennsylvania?
Yes, treatment history from other states counts. Provide complete documentation of previous therapies, including dates, doses, and reasons for discontinuation.

How much does Elelyso cost without insurance?
The wholesale acquisition cost (WAC) is approximately $839-$899 per 200-unit vial. Typical treatment requires multiple vials per infusion, making annual costs substantial without coverage.

What happens if Pennsylvania external review upholds the denial?
The external review decision is final for your current plan. You may explore alternative treatments, manufacturer assistance programs, or coverage through different insurance during open enrollment.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance company for guidance specific to your situation. Coverage policies and procedures may change. For additional assistance with insurance appeals in Pennsylvania, contact the Pennsylvania Insurance Department Consumer Services at (877) 881-6388.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.